MCK — McKesson Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for McKesson, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	238,228	263,966	276,711	308,951	359,051
Cost of Revenue
Gross Profit	12,284	13,286	12,358	12,584	12,879
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	243,268	262,119	272,330	305,033	354,629
Operating Profit	-5,040	1,847	4,381	3,918	4,422
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-5,034	1,928	4,630	3,789	4,359
Provision for Income Taxes
Net Income After Taxes	-4,339	1,292	3,725	3,160	3,481
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-4,539	1,114	3,560	3,002	3,295
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-4,539	1,114	3,560	3,002	3,295
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.05	13.4	26	22.4	29.6
Dividends per Share